Study
ER HER2 PR breast Cancer genome sequencing
Study ID | Alternative Stable ID | Type |
---|---|---|
EGAS00001000197 | Cancer Genomics |
Study Description
Agilent whole exome hybridisation capture will be performed on genomic DNA derived from X triple negative breast cancers and matched normal DNA from the same patients. Three lanes of Illumina GA sequencing will be performed on the resulting X exome libraries and mapped to build 37 of the human reference genome to facilitate the identification of novel cancer genes.
Study Datasets 2 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001000088 |
ER-, HER2-, PR- breast Cancer genome sequencing
|
Illumina Genome Analyzer II | 6 |
EGAD00001000133 |
The landscape of cancer genes and mutational processes in breast cancer
|
Illumina Genome Analyzer II,Illumina HiSeq 2000 | 199 |
Who archives the data?

Publications
Citations
Retrieving...

Retrieving...

Retrieving...

Retrieving...
